Published in Can J Oncol on February 01, 1996
Meta-analysis comparing higher and lower dose radiotherapy for palliation in locally advanced lung cancer. Cancer Sci (2014) 1.42
A comparative study of different dose fractionations schedule of thoracic radiotherapy for pain palliation and health-related quality of life in metastatic NSCLC. Lung India (2014) 0.96
Hypofractionated radiotherapy as local hemostatic agent in advanced cancer. Indian J Palliat Care (2011) 0.90
Clinical management of pain in advanced lung cancer. Clin Med Insights Oncol (2012) 0.81
Palliative radiation therapy for primary gastric melanoma. J Gastrointest Oncol (2014) 0.79
Effectiveness of radiation therapy alone for elderly patients with unresected stage III non-small cell lung cancer. Lung Cancer (2013) 0.77
Quality of life measurement in cancer patients receiving palliative radiotherapy for symptomatic lung cancer: a literature review. Curr Oncol (2009) 0.76
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med (1997) 8.72
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol (2010) 5.96
Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet (1994) 3.51
High-performance lithium-ion anodes using a hierarchical bottom-up approach. Nat Mater (2010) 3.25
Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (1994) 2.77
Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys (2001) 2.33
Do minutes count? Consultation lengths in general practice. J Health Serv Res Policy (1998) 2.23
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1993) 2.22
Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy? Clin Oncol (R Coll Radiol) (2004) 2.12
Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res (1994) 2.11
H2A.Z is required for global chromatin integrity and for recruitment of RNA polymerase II under specific conditions. Mol Cell Biol (2001) 2.11
High-intensity focused ultrasound for prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) (2010) 2.02
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol (1997) 1.90
Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. J Clin Oncol (1990) 1.88
Intensity-modulated radiotherapy in the treatment of lung cancer. Clin Oncol (R Coll Radiol) (2012) 1.74
The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys (2001) 1.70
Carcinoma of the prostate: results of radical radiotherapy (1970-1985). Int J Radiat Oncol Biol Phys (1993) 1.61
Adult paratesticular sarcomas: a review of 21 cases. J Urol (1991) 1.59
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
A management approach to incompletely excised basal cell carcinomas of skin. Int J Radiat Oncol Biol Phys (1991) 1.52
Controversies in prostate cancer radiotherapy: consensus development. Can J Urol (2001) 1.51
Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol (2002) 1.50
Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192. Radiother Oncol (1991) 1.50
Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue. Radiother Oncol (1990) 1.47
Dosimetry of intraluminal brachytherapy. Radiother Oncol (1992) 1.43
A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology (1999) 1.43
Intensity-modulated radiotherapy in the treatment of breast cancer. Clin Oncol (R Coll Radiol) (2012) 1.42
Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns (2001) 1.42
Management preferences following radical inguinal orchidectomy for Stage I testicular seminoma in Australasia. Australas Radiol (2002) 1.40
Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction With Doctor Questionnaire. J Clin Oncol (1999) 1.38
Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys (1999) 1.36
Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol (1999) 1.35
Communicating quality of life information to cancer patients: a study of six presentation formats. J Clin Oncol (2005) 1.31
Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol (2000) 1.30
Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1997) 1.29
Ribosomes in thiostrepton-resistant mutants of Bacillus megaterium lacking a single 50 S subunit protein. J Mol Biol (1979) 1.29
Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC. Eur Respir J (2012) 1.28
Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol (2001) 1.28
Value of whole brain re-irradiation for brain metastases--single centre experience. Clin Oncol (R Coll Radiol) (2007) 1.27
Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol (2001) 1.26
Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys (1993) 1.26
The influence of fish cage aquaculture on pelagic carbon flow and water chemistry in tidally dominated mangrove estuaries of peninsular Malaysia. Mar Environ Res (2003) 1.26
Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Support Care Cancer (1997) 1.24
An assessment of US and Canadian smoking reduction objectives for the year 2000. Am J Public Health (1998) 1.22
A comprehensive systematic review of testicular germ cell tumor surveillance. Crit Rev Oncol Hematol (2007) 1.22
Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys (2001) 1.21
The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin Oncol (R Coll Radiol) (2012) 1.21
Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis (1987) 1.21
Cancer Care Ontario Colonoscopy Standards: standards and evidentiary base. Can J Gastroenterol (2007) 1.20
University of Alberta norms of relative meaning frequency for 566 homographs. Mem Cognit (1994) 1.20
Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): a multiattribute health state classification system for prostate cancer. J Clin Epidemiol (2000) 1.18
Do doctors know when their patients don't? A survey of doctor-patient communication in lung cancer. Lung Cancer (1997) 1.17
Bone marrow metastasis in astrocytic gliomata. J Neurooncol (1998) 1.17
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points. J Clin Oncol (1998) 1.17
The impact of nursing grade on the quality and outcome of nursing care. Health Econ (1995) 1.16
Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response. J Clin Oncol (1984) 1.14
Physicians' perspective on quality of life: an exploratory study of oncologists. Qual Life Res (1996) 1.13
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res (1992) 1.12
Informed consent for clinical trials: is simpler better? J Natl Cancer Inst (1998) 1.10
Supportive care management of brain metastases: what is known and what we need to know. Conference proceedings of the National Cancer Institute of Canada (NCIC) Workshop on Symptom Control in Radiation Oncology. Clin Oncol (R Coll Radiol) (2003) 1.09
A structured review of quality of life instruments for head and neck cancer patients. Head Neck (2001) 1.06
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. J Clin Oncol (1991) 1.06
Volvulus of the sigmoid colon in Brazil: a report of 230 cases. Dis Colon Rectum (1976) 1.05
Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med (1993) 1.05
Fatal injuries and alcohol. Am J Prev Med (1988) 1.05
Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1998) 1.05
Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin Oncol (R Coll Radiol) (2012) 1.04
Intensity-modulated radiotherapy in the treatment of head and neck cancer. Clin Oncol (R Coll Radiol) (2012) 1.04
Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study. J Clin Oncol (2000) 1.04
The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Gynecol Oncol (2007) 1.03
Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol (1991) 1.03
A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma. Cancer (2001) 1.02
Site of action of clomiphene and its use as a test of pituitary function. J Obstet Gynaecol Br Commonw (1971) 1.01
Dynamic illusion effects in a reaching task: evidence for separate visual representations in the planning and control of reaching. J Exp Psychol Hum Percept Perform (2001) 1.01
Late onset in dysferlinopathy widens the clinical spectrum. Neuromuscul Disord (2008) 1.01
Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy. Dose, schedule, and route of administration. Support Care Cancer (1998) 1.00
Carcinoma of the maxillary antrum: a retrospective analysis of 110 cases. Radiother Oncol (2000) 1.00
A novel four-dimensional radiotherapy method for lung cancer: imaging, treatment planning and delivery. Phys Med Biol (2006) 0.98
Neoadjuvant hormonal therapy in carcinoma of the prostate. BJU Int (1999) 0.98
The prognostic significance of the tumour infiltrating lymphocyte count in stage I testicular seminoma managed by surveillance. Eur J Cancer (2002) 0.97
Waiting lists for radiation therapy: a case study. BMC Health Serv Res (2001) 0.97
Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2000) 0.97
"When you carry condoms all the boys think you want it": negotiating competing discourses about safe sex. J Adolesc (1998) 0.97
Childhood medulloblastoma in Ontario, 1977-1987: population-based results. Med Pediatr Oncol (1996) 0.97
Biopsy diagnosis of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. Eur J Cancer (2012) 0.96
Does age influence the behaviour of localized prostate cancer? BJU Int (2001) 0.96
Defining the impact and contribution of steroids in patients receiving whole-brain irradiation for cerebral metastases. Clin Oncol (R Coll Radiol) (2004) 0.95
Impact of noninvasive imaging on increased incidental detection of renal cell carcinoma. Eur Urol (2000) 0.95
Interobserver variation in prostate cancer Gleason scoring: are there implications for the design of clinical trials and treatment strategies? Clin Oncol (R Coll Radiol) (1997) 0.95
Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill. Prostate Cancer Prostatic Dis (2003) 0.95
Management of stage I seminomatous testicular cancer: a systematic review. Clin Oncol (R Coll Radiol) (2009) 0.94
Herpes simplex virus infection in rabbit eye. Arch Ophthalmol (1972) 0.94
Magnetic resonance imaging (MRI) for localization of the prostatic apex: comparison to computed tomography (CT) and urethrography. Radiother Oncol (1998) 0.93
The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol (2001) 0.92